Stay updated with breaking news from Lynda Mitchell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In this review of April 2024, the editorial team highlighted some of the biggest stories in the pulmonary health space, touching on topics such as air quality issues, asthma, and pneumonia.
The FDA approval of benralizumab for patients ages 6 to 11 with asthma follows the conclusions of the phase 3 TATE study.
Benralizumab was previously approved by the FDA in 2017 as an add-on maintenance therapy for patients 12 years and older.
Additional indication for pediatric patients with severe eosinophilic asthma ...
The approval of benralizumab (Fasenra) is supported by evidence from the phase 3 TATE study.